• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

Recent Advances in the Study of 2-(1S)-1-aminoethyl-1,3-oxazole-4-carboxylic acid (CAS: 1932457-85-6)

The compound 2-(1S)-1-aminoethyl-1,3-oxazole-4-carboxylic acid (CAS: 1932457-85-6) has recently garnered significant attention in the field of chemical biology and medicinal chemistry. This molecule, characterized by its unique oxazole ring and chiral aminoethyl side chain, has shown promising potential in various therapeutic applications. Recent studies have focused on its synthesis, pharmacological properties, and mechanisms of action, providing valuable insights for drug development.

One of the key areas of research involves the synthesis of 2-(1S)-1-aminoethyl-1,3-oxazole-4-carboxylic acid and its derivatives. A study published in the Journal of Medicinal Chemistry (2023) detailed an optimized synthetic route that improves yield and purity, making it more feasible for large-scale production. The researchers employed asymmetric catalysis to achieve high enantiomeric purity, which is critical for its biological activity. This advancement addresses previous challenges in the synthesis of this compound and opens new avenues for its application in drug discovery.

In terms of pharmacological properties, recent in vitro and in vivo studies have demonstrated that 2-(1S)-1-aminoethyl-1,3-oxazole-4-carboxylic acid exhibits potent inhibitory effects on specific enzymatic targets. For instance, it has been shown to selectively inhibit certain proteases involved in inflammatory pathways, suggesting its potential as an anti-inflammatory agent. Additionally, preliminary data from cell-based assays indicate that this compound may have antitumor activity, particularly in cancers with dysregulated signaling pathways.

Mechanistic studies have further elucidated the interaction of 2-(1S)-1-aminoethyl-1,3-oxazole-4-carboxylic acid with its biological targets. X-ray crystallography and molecular docking simulations have revealed that the compound binds to the active site of target enzymes with high affinity, disrupting their function. These findings are supported by kinetic studies, which show a competitive inhibition pattern. Such detailed mechanistic understanding is crucial for the rational design of more potent and selective derivatives.

Despite these promising results, challenges remain in the clinical translation of 2-(1S)-1-aminoethyl-1,3-oxazole-4-carboxylic acid. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed in future studies. Ongoing research is exploring structural modifications to enhance its pharmacokinetic profile while maintaining its therapeutic efficacy. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the development of this compound into a viable drug candidate.

In conclusion, the recent advancements in the study of 2-(1S)-1-aminoethyl-1,3-oxazole-4-carboxylic acid (CAS: 1932457-85-6) highlight its potential as a versatile scaffold in medicinal chemistry. The improved synthetic methods, detailed mechanistic insights, and promising pharmacological data collectively underscore its significance in drug discovery. Future research should focus on overcoming the existing challenges to fully realize its therapeutic potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)